Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
α-Synuclein (aSyn) is central to Parkinson's disease pathogenesis, yet its native physiological role at the presynapse remain poorly defined. Here, super-resolution imaging in dopaminergic neurons reveals that endogenous aSyn localises within nanometres of L-type voltage-gated calcium channels (LTCC), with closer proximity under both spontaneous neuronal activity and stimulated conditions compared to when extracellular calcium is chelated. Blocking Ca 2+ /calmodulin-dependent kinase II (CaMKII) reduces aSyn clustering at LTCC under spontaneous activity, suggesting that calcium entry and downstream calcium-dependent kinase activity contribute to aSyn localisation. Moreover, quantitative single-molecule analyses indicate that calcium increases the abundance of both total and serine129 phosphorylated (pS129) aSyn in synaptosomes under spontaneous conditions, and NMR analysis reveals that both calcium and S129 phosphorylation increase the binding affinity of aSyn to synaptic vesicles. Functional assays further demonstrate that LTCC blockade elevates intracellular DA levels exclusively in the presence of aSyn under spontaneous but not stimulated conditions. Finally, biochemical fractionation and multi-colour single-molecule imaging reveal that aSyn preferentially associates with small vesicles that are not obligately coupled to full-fusion associated recycling pools. These results suggest that aSyn acts as a calcium- and phosphorylation-regulated modulator of spontaneous DA release through pathways that are largely independent of full-fusion recycling mechanisms, and that pS129 aSyn is not solely a pathological marker but may also reflects physiological regulation. Together, these insights provide a framework for understanding how therapeutic strategies targeting aSyn may impact its normal synaptic functions.
Horst Arthur Vogel, Rudolf Hovius, Joachim Piguet